APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lysosomal Alpha Glucosidase

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lysosomal Alpha Glucosidase Industry Research Report 2026

Report ID 174009700519 December 2025125 pages

Choose your research edition.

Industry ResearchLysosomal Alpha Glucosidase Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysosomal Alpha Glucosidase Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Lysosomal Alpha Glucosidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysosomal Alpha Glucosidase Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysosomal Alpha Glucosidase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lysosomal Alpha Glucosidase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lysosomal Alpha Glucosidase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lysosomal Alpha Glucosidase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lysosomal Alpha Glucosidase include Sarepta Therapeutics Inc, Pharming Group NV, Oxyrane Belgium NV, JCR Pharmaceuticals Co Ltd, Huons Co Ltd, greenovation Biotech GmbH, Genzyme Corp, Etubics Corp and Audentes Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lysosomal Alpha Glucosidase market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lysosomal Alpha Glucosidase Market by Company

Sarepta Therapeutics Inc

Pharming Group NV

Oxyrane Belgium NV

JCR Pharmaceuticals Co Ltd

Huons Co Ltd

greenovation Biotech GmbH

Genzyme Corp

Etubics Corp

Audentes Therapeutics Inc

Amicus Therapeutics Inc

Lysosomal Alpha Glucosidase Segment by Type

AT-982

ATB-200

AVRRD-03

JR-162

MOSS-GAA

OXY-2810

Others

Lysosomal Alpha Glucosidase Segment by Application

Glycogen Storage Disease

Pompe Disease

Others

Lysosomal Alpha Glucosidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysosomal Alpha Glucosidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysosomal Alpha Glucosidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysosomal Alpha Glucosidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lysosomal Alpha Glucosidase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lysosomal Alpha Glucosidase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lysosomal Alpha Glucosidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lysosomal Alpha Glucosidase Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lysosomal Alpha Glucosidase Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lysosomal Alpha Glucosidase Revenue of Manufacturers (2021-2026) Table 9. Global Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lysosomal Alpha Glucosidase Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lysosomal Alpha Glucosidase Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lysosomal Alpha Glucosidase, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lysosomal Alpha Glucosidase, Product Type & Application Table 14. Global Lysosomal Alpha Glucosidase Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lysosomal Alpha Glucosidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sarepta Therapeutics Inc Company Information Table 19. Sarepta Therapeutics Inc Business Overview Table 20. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 22. Sarepta Therapeutics Inc Recent Developments Table 23. Pharming Group NV Company Information Table 24. Pharming Group NV Business Overview Table 25. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio Table 27. Pharming Group NV Recent Developments Table 28. Oxyrane Belgium NV Company Information Table 29. Oxyrane Belgium NV Business Overview Table 30. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio Table 32. Oxyrane Belgium NV Recent Developments Table 33. JCR Pharmaceuticals Co Ltd Company Information Table 34. JCR Pharmaceuticals Co Ltd Business Overview Table 35. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 37. JCR Pharmaceuticals Co Ltd Recent Developments Table 38. Huons Co Ltd Company Information Table 39. Huons Co Ltd Business Overview Table 40. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 42. Huons Co Ltd Recent Developments Table 43. greenovation Biotech GmbH Company Information Table 44. greenovation Biotech GmbH Business Overview Table 45. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio Table 47. greenovation Biotech GmbH Recent Developments Table 48. Genzyme Corp Company Information Table 49. Genzyme Corp Business Overview Table 50. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio Table 52. Genzyme Corp Recent Developments Table 53. Etubics Corp Company Information Table 54. Etubics Corp Business Overview Table 55. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio Table 57. Etubics Corp Recent Developments Table 58. Audentes Therapeutics Inc Company Information Table 59. Audentes Therapeutics Inc Business Overview Table 60. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 62. Audentes Therapeutics Inc Recent Developments Table 63. Amicus Therapeutics Inc Company Information Table 64. Amicus Therapeutics Inc Business Overview Table 65. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 67. Amicus Therapeutics Inc Recent Developments Table 68. Global Lysosomal Alpha Glucosidase Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026) & (K Units) Table 70. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2026) Table 71. Global Lysosomal Alpha Glucosidase Sales by Region (2027-2032) & (K Units) Table 72. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2027-2032) Table 73. Global Lysosomal Alpha Glucosidase Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2026) Table 75. Global Lysosomal Alpha Glucosidase Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2027-2032) Table 77. North America Lysosomal Alpha Glucosidase Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 79. North America Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 80. North America Lysosomal Alpha Glucosidase Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Lysosomal Alpha Glucosidase Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Lysosomal Alpha Glucosidase Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 84. Europe Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 85. Europe Lysosomal Alpha Glucosidase Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Lysosomal Alpha Glucosidase Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Lysosomal Alpha Glucosidase Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Lysosomal Alpha Glucosidase Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Lysosomal Alpha Glucosidase Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Lysosomal Alpha Glucosidase Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 94. South America Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 95. South America Lysosomal Alpha Glucosidase Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Lysosomal Alpha Glucosidase Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 103. Global Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 104. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2026) Table 105. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2027-2032) Table 106. Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2026) Table 109. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2027-2032) Table 110. Global Lysosomal Alpha Glucosidase Price by Type (2021-2026) & (US$/Unit) Table 111. Global Lysosomal Alpha Glucosidase Price by Type (2027-2032) & (US$/Unit) Table 112. Global Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 113. Global Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 114. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2026) Table 115. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2027-2032) Table 116. Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2026) Table 119. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2027-2032) Table 120. Global Lysosomal Alpha Glucosidase Price by Application (2021-2026) & (US$/Unit) Table 121. Global Lysosomal Alpha Glucosidase Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Lysosomal Alpha Glucosidase Distributors List Table 125. Lysosomal Alpha Glucosidase Customers List Table 126. Lysosomal Alpha Glucosidase Industry Trends Table 127. Lysosomal Alpha Glucosidase Industry Drivers Table 128. Lysosomal Alpha Glucosidase Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lysosomal Alpha Glucosidase Product Image Figure 5. Global Lysosomal Alpha Glucosidase Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lysosomal Alpha Glucosidase Market Size (2021-2032) & (US$ Million) Figure 7. Global Lysosomal Alpha Glucosidase Sales (2021-2032) & (K Units) Figure 8. Global Lysosomal Alpha Glucosidase Average Price (US$/Unit) & (2021-2032) Figure 9. AT-982 Product Image Figure 10. ATB-200 Product Image Figure 11. AVRRD-03 Product Image Figure 12. JR-162 Product Image Figure 13. MOSS-GAA Product Image Figure 14. OXY-2810 Product Image Figure 15. Others Product Image Figure 16. Glycogen Storage Disease Product Image Figure 17. Pompe Disease Product Image Figure 18. Others Product Image Figure 19. Global Lysosomal Alpha Glucosidase Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Lysosomal Alpha Glucosidase, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Lysosomal Alpha Glucosidase Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Lysosomal Alpha Glucosidase Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Lysosomal Alpha Glucosidase Sales by Region in 2025 Figure 25. Global Lysosomal Alpha Glucosidase Revenue by Region in 2025 Figure 26. North America Lysosomal Alpha Glucosidase Market Size by Country in 2025 Figure 27. North America Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 28. North America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2021-2032) Figure 29. United States Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Lysosomal Alpha Glucosidase Market Size by Country in 2025 Figure 32. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 33. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country (2021-2032) Figure 34. Germany Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Lysosomal Alpha Glucosidase Market Size by Country in 2025 Figure 40. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Lysosomal Alpha Glucosidase Revenue Market Share by Country (2021-2032) Figure 42. China Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Lysosomal Alpha Glucosidase Market Size by Country in 2025 Figure 51. South America Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 52. South America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2021-2032) Figure 53. Mexico Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Lysosomal Alpha Glucosidase Market Size by Country in 2025 Figure 57. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country (2021-2032) Figure 59. Turkey Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Lysosomal Alpha Glucosidase Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032) Figure 63. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032) Figure 64. Global Lysosomal Alpha Glucosidase Price (US$/Unit) by Type (2021-2032) Figure 65. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032) Figure 66. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032) Figure 67. Global Lysosomal Alpha Glucosidase Price (US$/Unit) by Application (2021-2032) Figure 68. Lysosomal Alpha Glucosidase Value Chain Figure 69. Lysosomal Alpha Glucosidase Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Lysosomal Alpha Glucosidase Industry Opportunities and Challenges

Scope & coverage.

Types
  • AT-982
  • ATB-200
  • AVRRD-03
  • JR-162
  • MOSS-GAA
  • OXY-2810
  • Others
Applications
  • Glycogen Storage Disease
  • Pompe Disease
  • Others
Companies covered
  • Sarepta Therapeutics Inc
  • Pharming Group NV
  • Oxyrane Belgium NV
  • JCR Pharmaceuticals Co Ltd
  • Huons Co Ltd
  • greenovation Biotech GmbH
  • Genzyme Corp
  • Etubics Corp
  • Audentes Therapeutics Inc
  • Amicus Therapeutics Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lysosomal Alpha Glucosidase Market Size (2021-2032)
  4. 2.2.2 Global Lysosomal Alpha Glucosidase Sales (2021-2032)
  5. 2.2.3 Global Lysosomal Alpha Glucosidase Market Average Price (2021-2032)
  6. 2.3 Lysosomal Alpha Glucosidase by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 AT-982
  9. 2.3.3 ATB-200
  10. 2.3.4 AVRRD-03
  11. 2.3.5 JR-162
  12. 2.3.6 MOSS-GAA
  13. 2.3.7 OXY-2810
  14. 2.3.8 Others
  15. 2.4 Lysosomal Alpha Glucosidase by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Glycogen Storage Disease
  18. 2.4.3 Pompe Disease
  19. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lysosomal Alpha Glucosidase Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lysosomal Alpha Glucosidase Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lysosomal Alpha Glucosidase Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lysosomal Alpha Glucosidase Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lysosomal Alpha Glucosidase Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lysosomal Alpha Glucosidase, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lysosomal Alpha Glucosidase, Product Type & Application
  8. 3.8 Global Manufacturers of Lysosomal Alpha Glucosidase, Established Date
  9. 3.9 Global Lysosomal Alpha Glucosidase Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sarepta Therapeutics Inc
  2. 4.1.1 Sarepta Therapeutics Inc Company Information
  3. 4.1.2 Sarepta Therapeutics Inc Business Overview
  4. 4.1.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  6. 4.1.5 Sarepta Therapeutics Inc Recent Developments
  7. 4.2 Pharming Group NV
  8. 4.2.1 Pharming Group NV Company Information
  9. 4.2.2 Pharming Group NV Business Overview
  10. 4.2.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio
  12. 4.2.5 Pharming Group NV Recent Developments
  13. 4.3 Oxyrane Belgium NV
  14. 4.3.1 Oxyrane Belgium NV Company Information
  15. 4.3.2 Oxyrane Belgium NV Business Overview
  16. 4.3.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio
  18. 4.3.5 Oxyrane Belgium NV Recent Developments
  19. 4.4 JCR Pharmaceuticals Co Ltd
  20. 4.4.1 JCR Pharmaceuticals Co Ltd Company Information
  21. 4.4.2 JCR Pharmaceuticals Co Ltd Business Overview
  22. 4.4.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  24. 4.4.5 JCR Pharmaceuticals Co Ltd Recent Developments
  25. 4.5 Huons Co Ltd
  26. 4.5.1 Huons Co Ltd Company Information
  27. 4.5.2 Huons Co Ltd Business Overview
  28. 4.5.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  30. 4.5.5 Huons Co Ltd Recent Developments
  31. 4.6 greenovation Biotech GmbH
  32. 4.6.1 greenovation Biotech GmbH Company Information
  33. 4.6.2 greenovation Biotech GmbH Business Overview
  34. 4.6.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio
  36. 4.6.5 greenovation Biotech GmbH Recent Developments
  37. 4.7 Genzyme Corp
  38. 4.7.1 Genzyme Corp Company Information
  39. 4.7.2 Genzyme Corp Business Overview
  40. 4.7.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio
  42. 4.7.5 Genzyme Corp Recent Developments
  43. 4.8 Etubics Corp
  44. 4.8.1 Etubics Corp Company Information
  45. 4.8.2 Etubics Corp Business Overview
  46. 4.8.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio
  48. 4.8.5 Etubics Corp Recent Developments
  49. 4.9 Audentes Therapeutics Inc
  50. 4.9.1 Audentes Therapeutics Inc Company Information
  51. 4.9.2 Audentes Therapeutics Inc Business Overview
  52. 4.9.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  54. 4.9.5 Audentes Therapeutics Inc Recent Developments
  55. 4.10 Amicus Therapeutics Inc
  56. 4.10.1 Amicus Therapeutics Inc Company Information
  57. 4.10.2 Amicus Therapeutics Inc Business Overview
  58. 4.10.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  60. 4.10.5 Amicus Therapeutics Inc Recent Developments
5 Global Lysosomal Alpha Glucosidase Market Scenario by Region
  1. 5.1 Global Lysosomal Alpha Glucosidase Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lysosomal Alpha Glucosidase Sales by Region: 2021-2032
  3. 5.2.1 Global Lysosomal Alpha Glucosidase Sales by Region: 2021-2026
  4. 5.2.2 Global Lysosomal Alpha Glucosidase Sales by Region: 2027-2032
  5. 5.3 Global Lysosomal Alpha Glucosidase Revenue by Region: 2021-2032
  6. 5.3.1 Global Lysosomal Alpha Glucosidase Revenue by Region: 2021-2026
  7. 5.3.2 Global Lysosomal Alpha Glucosidase Revenue by Region: 2027-2032
  8. 5.4 North America Lysosomal Alpha Glucosidase Market Facts & Figures by Country
  9. 5.4.1 North America Lysosomal Alpha Glucosidase Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  11. 5.4.3 North America Lysosomal Alpha Glucosidase Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Lysosomal Alpha Glucosidase Market Facts & Figures by Country
  15. 5.5.1 Europe Lysosomal Alpha Glucosidase Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  17. 5.5.3 Europe Lysosomal Alpha Glucosidase Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Lysosomal Alpha Glucosidase Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Lysosomal Alpha Glucosidase Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Lysosomal Alpha Glucosidase Market Facts & Figures by Country
  35. 5.7.1 South America Lysosomal Alpha Glucosidase Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  37. 5.7.3 South America Lysosomal Alpha Glucosidase Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Lysosomal Alpha Glucosidase Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Lysosomal Alpha Glucosidase Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  2. 6.1.1 Global Lysosomal Alpha Glucosidase Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  5. 6.2.1 Global Lysosomal Alpha Glucosidase Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lysosomal Alpha Glucosidase Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  2. 7.1.1 Global Lysosomal Alpha Glucosidase Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  5. 7.2.1 Global Lysosomal Alpha Glucosidase Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lysosomal Alpha Glucosidase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lysosomal Alpha Glucosidase Value Chain Analysis
  2. 8.1.1 Lysosomal Alpha Glucosidase Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lysosomal Alpha Glucosidase Production Mode & Process
  5. 8.2 Lysosomal Alpha Glucosidase Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lysosomal Alpha Glucosidase Distributors
  8. 8.2.3 Lysosomal Alpha Glucosidase Customers
9 Global Lysosomal Alpha Glucosidase Analyzing Market Dynamics
  1. 9.1 Lysosomal Alpha Glucosidase Industry Trends
  2. 9.2 Lysosomal Alpha Glucosidase Industry Drivers
  3. 9.3 Lysosomal Alpha Glucosidase Industry Opportunities and Challenges
  4. 9.4 Lysosomal Alpha Glucosidase Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst